These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 28984800)

  • 1. Pediatric cancer genetics.
    Dean SJ; Farmer M
    Curr Opin Pediatr; 2017 Dec; 29(6):629-633. PubMed ID: 28984800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toward Concurrent Testing for Somatic and Germline Variants in Cancer Patients.
    Mandelker D
    Clin Cancer Res; 2016 Aug; 22(16):3987-8. PubMed ID: 27307597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. When Should Tumor Genomic Profiling Prompt Consideration of Germline Testing?
    DeLeonardis K; Hogan L; Cannistra SA; Rangachari D; Tung N
    J Oncol Pract; 2019 Sep; 15(9):465-473. PubMed ID: 31509718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Germline Variants in Targeted Tumor Sequencing Using Matched Normal DNA.
    Schrader KA; Cheng DT; Joseph V; Prasad M; Walsh M; Zehir A; Ni A; Thomas T; Benayed R; Ashraf A; Lincoln A; Arcila M; Stadler Z; Solit D; Hyman DM; Zhang L; Klimstra D; Ladanyi M; Offit K; Berger M; Robson M
    JAMA Oncol; 2016 Jan; 2(1):104-11. PubMed ID: 26556299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The emerging significance of secondary germline testing in cancer genomics.
    Mandelker D; Zhang L
    J Pathol; 2018 Apr; 244(5):610-615. PubMed ID: 29293272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. "Somatic" Tumor Genomic Profiling and Potential Germline Implications: Ethical Considerations for Children with Cancer.
    Knapp E
    J Law Med Ethics; 2020 Dec; 48(4):778-783. PubMed ID: 33404327
    [No Abstract]   [Full Text] [Related]  

  • 7. Germline potential should not be overlooked for cancer variants identified in tumour-only somatic mutation testing.
    Al-Shinnag M; Cheong PL; Goodwin A; Trent R; Yu B
    Pathology; 2024 Jun; 56(4):468-472. PubMed ID: 38627125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a Variety of Mutations in Cancer Predisposition Genes in Patients With Suspected Lynch Syndrome.
    Yurgelun MB; Allen B; Kaldate RR; Bowles KR; Judkins T; Kaushik P; Roa BB; Wenstrup RJ; Hartman AR; Syngal S
    Gastroenterology; 2015 Sep; 149(3):604-13.e20. PubMed ID: 25980754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Speaking genomics to parents offered germline testing for cancer predisposition: Use of a 2-visit consent model.
    Johnson LM; Sykes AD; Lu Z; Valdez JM; Gattuso J; Gerhardt E; Hamilton KV; Harrison LW; Hines-Dowell SJ; Jurbergs N; McGee RB; Nuccio R; Ouma AA; Pritchard M; Quinn EA; Baker JN; Mandrell BN; Nichols KE
    Cancer; 2019 Jul; 125(14):2455-2464. PubMed ID: 30901077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of clinically relevant germline variants detected by next-generation sequencing in patients with childhood cancer: a review of the literature.
    Sylvester DE; Chen Y; Jamieson RV; Dalla-Pozza L; Byrne JA
    J Med Genet; 2018 Dec; 55(12):785-793. PubMed ID: 30287599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recommendations for somatic and germline genetic testing of single pheochromocytoma and paraganglioma based on findings from a series of 329 patients.
    Currás-Freixes M; Inglada-Pérez L; Mancikova V; Montero-Conde C; Letón R; Comino-Méndez I; Apellániz-Ruiz M; Sánchez-Barroso L; Aguirre Sánchez-Covisa M; Alcázar V; Aller J; Álvarez-Escolá C; Andía-Melero VM; Azriel-Mira S; Calatayud-Gutiérrez M; Díaz JÁ; Díez-Hernández A; Lamas-Oliveira C; Marazuela M; Matias-Guiu X; Meoro-Avilés A; Patiño-García A; Pedrinaci S; Riesco-Eizaguirre G; Sábado-Álvarez C; Sáez-Villaverde R; Sainz de Los Terreros A; Sanz Guadarrama Ó; Sastre-Marcos J; Scolá-Yurrita B; Segura-Huerta Á; Serrano-Corredor Mde L; Villar-Vicente MR; Rodríguez-Antona C; Korpershoek E; Cascón A; Robledo M
    J Med Genet; 2015 Oct; 52(10):647-56. PubMed ID: 26269449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Germline genetic landscape of pediatric central nervous system tumors.
    Muskens IS; Zhang C; de Smith AJ; Biegel JA; Walsh KM; Wiemels JL
    Neuro Oncol; 2019 Nov; 21(11):1376-1388. PubMed ID: 31247102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor-Based Genetic Testing and Familial Cancer Risk.
    Forman A; Sotelo J
    Cold Spring Harb Perspect Med; 2020 Aug; 10(8):. PubMed ID: 31570381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of germline pathogenic variants in 22 cancer susceptibility genes in Swedish pediatric cancer patients.
    von Stedingk K; Stjernfelt KJ; Kvist A; Wahlström C; Kristoffersson U; Stenmark-Askmalm M; Wiebe T; Hjorth L; Koster J; Olsson H; Øra I
    Sci Rep; 2021 Mar; 11(1):5307. PubMed ID: 33674644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Time to incorporate germline multigene panel testing into breast and ovarian cancer patient care.
    Graffeo R; Livraghi L; Pagani O; Goldhirsch A; Partridge AH; Garber JE
    Breast Cancer Res Treat; 2016 Dec; 160(3):393-410. PubMed ID: 27734215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Genetic background and treatment of pediatric ALL].
    Kato M
    Rinsho Ketsueki; 2018; 59(10):2268-2272. PubMed ID: 30305535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer Predisposition Sequencing Reporter (CPSR): A flexible variant report engine for high-throughput germline screening in cancer.
    Nakken S; Saveliev V; Hofmann O; Møller P; Myklebost O; Hovig E
    Int J Cancer; 2021 Dec; 149(11):1955-1960. PubMed ID: 34310709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Germline mutations and new copy number variants among 40 pediatric cancer patients suspected for genetic predisposition.
    Gambale A; Russo R; Andolfo I; Quaglietta L; De Rosa G; Contestabile V; De Martino L; Genesio R; Pignataro P; Giglio S; Capasso M; Parasole R; Pasini B; Iolascon A
    Clin Genet; 2019 Oct; 96(4):359-365. PubMed ID: 31278746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expanding the spectrum of germline variants in cancer.
    Siraj AK; Masoodi T; Bu R; Parvathareddy SK; Al-Badawi IA; Al-Sanea N; Ashari LH; Abduljabbar A; Alhomoud S; Al-Sobhi SS; Tulbah A; Ajarim D; Alzoman K; Aljuboury M; Yousef HB; Al-Dawish M; Al-Dayel F; Alkuraya FS; Al-Kuraya KS
    Hum Genet; 2017 Nov; 136(11-12):1431-1444. PubMed ID: 28975465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of hereditary cancer gene panels on clinical care and lessons learned.
    Okur V; Chung WK
    Cold Spring Harb Mol Case Stud; 2017 Nov; 3(6):. PubMed ID: 29162654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.